Abstract
Hemerythrin is a dioxygen-carrying protein whose oxidative/nitrosative stress-related reactivity is lower than that of hemoglobin, which may warrant investigation of hemerythrin as raw material for artificial oxygen carriers (‘blood substitutes’). We report here the first biological tests for hemerythrin and its chemical derivatives, comparing their performance with that of a representative competitor, glutaraldehyde-polymerized bovine hemoglobin. Hemerythrin (native or derivatized) exhibits a proliferative effect on human umbilical vein endothelial cell (HUVEC) cultures, as opposed to a slight inhibitory effect of hemoglobin. A similar positive effect is displayed on human lymphocytes by glutaraldehyde-polymerized hemerythrin, but not by native or polyethylene glycol-derivatized hemerythrin.
Similar content being viewed by others
Abbreviations
- ANOVA:
-
analysis of variance
- FCS:
-
fetal calf serum
- Hb:
-
hemoglobin
- Hr:
-
Hemerythrin
- HUVEC:
-
human umbilical vein endothelial cell
- MTS:
-
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethonyphenol)-2-(4-sulfophenyl)-2H-tetrazolium
- MTT:
-
3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide
- PBS:
-
phosphate buffer saline
- PEG-Hr:
-
polyethylene glycol-derivatized Hr
- PMS:
-
phenazine methosulphate
References
Alayash AI 2004 Oxygen therapeutics: can we tame haemoglobin? Nat. Rev. Drug Discov. 3 152–159
Antonini E and Brunori M 1971 Hemoglobin and myoglobin in their reaction with ligands (Amsterdam: North-Holland)
Arafat WO, Casado E, Wang M, Alvarez RD, Siegal GP, Glorioso JC, Curiel DT and Gomez-Navarro J 2000 Genetically modified CD34+ cells exert a cytotoxic bystander effect on human endothelial and cancer cells. Clin. Cancer Res. 6 4442–4448
Blomberg LM, Blomberg MRA and Siegbahn PEM 2004 A theoretical study of myoglobin working as a nitric oxide scavenger. J. Biol. Inorg. Chem. 9 923–935
Cooper CE, Silaghi-Dumitrescu R, Rukengwa M, Alayash AI and Buehler PW 2008 Peroxidase activity of hemoglobin towards ascorbate and urate: a synergistic protective strategy against toxicity of hemoglobin-based oxygen carriers (HBOC). Biochim. Biophys. Acta 1784 1415–1420
Creteur J and Vincent JL 2009 Potential uses of hemoglobin-based oxygen carriers in critical care medicine. Crit. Care Clin. 25 311–324, Table of Contents
D'Agnillo F and Alayash A 2001 Redoc cycling of diaspirin crosslinked hemoglobin induces G2/M arrest and apoptosis in cultured endothelial cells. Blood 98 3315–3323
Deac F, Todea A and Silaghi-Dumitrescu R 2009 Glutaraldehyde derivatization of hemoglobin: a potential blood substitute; in Metal elements in environment, medicine and biology tome IX (eds.) R Silaghi-Dumitrescu and G Garban (Cluj-Napoca, Romania: Cluj University Press) pp. 165–173
Denizot F and Lang R 1986 Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Method. 89 271–277
Farmer CS, Kurtz DM Jr, Phillips RS, Ai J and Sanders-Loehr J 2000 A leucine residue "Gates" solvent but not O2 access to the binding pocket of phascolopsis gouldii hemerythrin. J. Biol. Chem. 275 17043–17050
Furukawa T, Kubota T, Suto A, Takahara T, Yamaguchi H, Takeuchi T, Kase S, Kodaira S, Ishibiki K and Kitajima M 1991 Clinical usefulness of chemosensitivity testing using the MTT assay. J. Surg. Oncol. 48 188–193
Herold S 1998 Kinetic and spectroscopic characterization of an intermediate peroxynitrite complex in the nitrogen monoxide induced oxidation of oxyhemoglobin. FEBS Lett. 439 85–88
Herold S, Exner M and Nauser T 2001 Kinetic and mechanistic studies of the NO*-mediated oxidation of oxymyoglobin and oxyhemoglobin. Biochemistry 40 3385–3395
Jin S, Kurtz DM Jr, Liu ZJ, Rose J and Wang BC 2002 X-ray crystal structures of reduced rubrerythrin and its azide adduct: a structure-based mechanism for a non-heme diiron peroxidase. J. Am. Chem. Soc. 124 9845–9855
Kryatov SV, Rybak-Akimova EV and Schindler S 2005 Kinetics and mechanisms of formation and reactivity of non-heme iron oxygen intermediates. Chem. Rev. 105 2175–2226
Malkevich NV, Dong F, Vandermolen CA, Philbin NB, Rice JP, Scultetus A, Hong J, Arnaud F, et al. 2008 Innate immune response after resuscitation with hemoglobin-based oxygen carrier and recombinant factor VIIA in uncontrolled hemorrhagic shock in a swine model. J. Trauma 64 1498–1510
McLeod LL and Alayash AI 1999 Detection of a ferrylhemoglobin intermediate in an endothelial cell model after hypoxia-reoxygenation. Am. J. Physiol.-Heart Circul. Physiol. 277 H92–H99
Mot AC, Roman A, Lupan I, Kurtz DM Jr and Silaghi-Dumitrescu R 2010 Towards the development of hemerythrin-based blood substitutes. Protein J. 29 387–393
Olson JS, Foley EW, Rogge C, Tsai AL, Doyle MP and Lemon DD 2004 NO scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radical Biol. Med. 36 685–697
Reeder BJ, Grey M, Silaghi-Dumitrescu RL, Svistunenko DA, Bulow L, Cooper CE and Wilson MT 2008 Tyrosine residues as redox cofactors in human hemoglobin: implications for engineering nontoxic blood substitutes. J. Biol. Chem. 283 30780–30787
Reeder BJ, Sharpe MA, Kay AD, Kerr M, Moore K and Wilson MT 2002a Toxicity of myoglobin and haemoglobin: oxidative stress in patients with rhabdomyolysis and subarachnoid haemorrhage. Biochem. Soc. Trans. 30 745–748
Reeder BJ, Svistunenko DA, Cooper CE and Wilson MT 2004 The radical and redox chemistry of myoglobin and hemoglobin: from in vitro studies to human pathology. Antioxid. Redox Sign. 6 954–966
Reeder BJ, Svistunenko DA, Sharpe MA and Wilson MT 2002b Characteristics and mechanism of formation of peroxide-induced heme to protein cross-linking in myoglobin. Biochemistry 41 367–375
Silaghi-Dumitrescu R and Silaghi-Dumitrescu I 2006 DFT and the electromerism in complexes of iron with diatomic ligands. J. Inorg. Biochem. 100 161–166
Tsuchida E, Sou K, Nakagawa A, Sakai H, Komatsu T and Kobayashi K 2009 Artificial oxygen carriers, hemoglobin vesicles and albumin-hemes, based on bioconjugate chemistry. Bioconjug. Chem. 20 1419–1440
Vollaard NB, Reeder BJ, Shearman JP, Menu P, Wilson MT and Cooper CE 2005a A new sensitive assay reveals that hemoglobin is oxidatively modified in vivo. Free Radical Biol. Med. 39 1216–1228
Vollaard NB, Shearman JP and Cooper CE 2005b Exercise-induced oxidative stress:myths, realities and physiological relevance. Sports Med. 35 1045–1062
Wang P, Henning SM and Heber D 2010 Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols. PLoS One 5 e10202
Acknowledgements
This work was supported by the Romanian Ministry for Education and Research (grants PNII ID565/2007 and PCCE 140/2008) and by PhD scholarships to FD and AM (Contract POSDRU/88/1.5/S/60185 – ‘Innovative doctoral studies in a knowledge based society’).
Author information
Authors and Affiliations
Additional information
[Fischer-Fodor E, Mot A, Deac F, Arkosi M, Silaghi-Dumitrescu R 2011 Towards hemerythrin-based blood substitutes: Comparative performance to hemoglobin on human leukocytes and umbilical vein endothelial cells. J. Biosci. 36 XXX–XXX] DOI
Rights and permissions
About this article
Cite this article
Fischer-Fodor, E., Mot, A., Deac, F. et al. Towards hemerythrin-based blood substitutes: Comparative performance to hemoglobin on human leukocytes and umbilical vein endothelial cells. J Biosci 36, 215–221 (2011). https://doi.org/10.1007/s12038-011-9066-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12038-011-9066-5